Free Trial
ASX:EBO

EBOS Group (EBO) Stock Price, News & Analysis

EBOS Group logo

About EBOS Group Stock (ASX:EBO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
4,371 shs
Average Volume
N/A
Market Capitalization
$8.20 billion
P/E Ratio
27.51
Dividend Yield
2.31%
Price Target
N/A
Consensus Rating
N/A

Company Overview

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, New Zealand, and Southeast Asia. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Receive EBO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for EBOS Group and its competitors with MarketBeat's FREE daily newsletter.

EBO Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Jarden Remains a Buy on EBOS Group Limited (EBO)
Citi Sticks to Its Sell Rating for EBOS Group Limited (EBO)
Ord Minnett Sticks to Its Buy Rating for EBOS Group Limited (EBO)
UBS launch $NZ217m EBOS Group placement
See More Headlines

EBO Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that EBOS Group investors own include Take-Two Interactive Software (TTWO), Snowflake (SNOW), Shopify (SHOP), Meridian Energy (MEZ), ikeGPS Group (IKE), Infratil (IFT) and HEXO (HEXO).

Company Calendar

Ex-Dividend for 3/20 Dividend
2/26/2025
Record date for 3/20 Dividend
3/20/2025
Dividend Payable
3/20/2025
Today
4/26/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
ASX:EBO
CIK
N/A
Fax
N/A
Employees
5,000
Year Founded
N/A

Profitability

Trailing P/E Ratio
27.51
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$271.55 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$13.19 billion
Price / Cash Flow
12.24
Book Value
A$13.72 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8.20 billion
Optionable
Not Optionable
Beta
0.26

This page (ASX:EBO) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners